Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

148.03 -2.98 (-1.97%)
Official Closing Price Updated: 7:00 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,885,698
Open 151.65
Bid (Size) 147.20 (1)
Ask (Size) 147.98 (7)
Prev. Close 151.01
Today's Range 147.19 - 152.00
52wk Range 105.56 - 175.91
Shares Outstanding N/A
Dividend Yield 3.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
If You Invested $1000 In AbbVie 5 Years Ago, Here's How Much You Would Have Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 7.1% on an annualized basis producing an average annual return of 17.45%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
 
Via Benzinga

Performance

YTD
+9.31%
+9.31%
1 Month
-4.49%
-4.49%
3 Month
+1.70%
+1.70%
6 Month
+28.00%
+28.00%
1 Year
+27.71%
+27.71%

More News

Read More
What 8 Analyst Ratings Have To Say About AbbVie
Via Benzinga
EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis
Via Benzinga
AbbVie Submits FDA Application For Continuous, 24-Hour Infusion Therapy For Parkinson's
Via Benzinga
AbbVie, Cugene Ink Licensing Pact For Autoimmune & Inflammatory Disease Candidate
Via Benzinga
CNBC's Final Trades: AbbVie, Costco Wholesale, Deere And This Kevin O'Leary Pick
Via Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Via Benzinga
7 Quality Dividend Stocks to Buy on the Dip
Via InvestorPlace
7 Retirement Stocks to Buy for Any Market Conditions
Via InvestorPlace
AbbVie's Upadacitinib Shows Clinical Response In Crohn's Disease Maintenance Study At One Year
Via Benzinga
9 Stocks Moved By Traders On 'Fast Money: Halftime Report'
Via Benzinga
AbbVie Whale Trades Spotted
Via Benzinga
6 Stocks to Buy to Hedge Your Portfolio in a Down Market
Via InvestorPlace
7 Best Value Stocks to Buy if You Need Some Market Stability in Your Life
Via InvestorPlace
Why Orphan Drug Designation Offers Several Benefits
Via FinancialNewsMedia
Exposures Product Safety
Warren Buffett Stocks: Berkshire Hathaway Goes On Offense In Stock Market, Adds More Apple
Via Investor's Business Daily
The 5 Best Dividend Stocks to Buy Now
Via InvestorPlace
7 Retirement Stocks for Steady Long-Term Income Growth
Via InvestorPlace
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Via Talk Markets
7 Profitable Places to Hide Your Money During a Bear Market
Via InvestorPlace
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
Via Investor's Business Daily
Investor Action Alert: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
The Top 10 Stocks Helping Warren Buffett Beat the Market
Via InvestorPlace
Shareholder Action Notice: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.